These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11576338)

  • 1. A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease.
    Dell KM; Nemo R; Sweeney WE; Levin JI; Frost P; Avner ED
    Kidney Int; 2001 Oct; 60(4):1240-8. PubMed ID: 11576338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability.
    Sweeney WE; Hamahira K; Sweeney J; Garcia-Gatrell M; Frost P; Avner ED
    Kidney Int; 2003 Oct; 64(4):1310-9. PubMed ID: 12969149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.
    Nemo R; Murcia N; Dell KM
    Pediatr Res; 2005 May; 57(5 Pt 1):732-7. PubMed ID: 15774823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF-related growth factors in the pathogenesis of murine ARPKD.
    MacRae Dell K; Nemo R; Sweeney WE; Avner ED
    Kidney Int; 2004 Jun; 65(6):2018-29. PubMed ID: 15149315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD.
    Sweeney WE; Kusner L; Carlin CR; Chang S; Futey L; Cotton CU; Dell KM; Avner ED
    Am J Physiol Cell Physiol; 2001 Nov; 281(5):C1695-705. PubMed ID: 11600434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice.
    Nakanishi K; Gattone VH; Sweeney WE; Avner ED
    Pediatr Nephrol; 2001 Jan; 16(1):45-50. PubMed ID: 11198603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability?
    Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.
    Sweeney WE; Chen Y; Nakanishi K; Frost P; Avner ED
    Kidney Int; 2000 Jan; 57(1):33-40. PubMed ID: 10620185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells.
    Veizis IE; Cotton CU
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F474-82. PubMed ID: 15522985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
    Torres VE; Sweeney WE; Wang X; Qian Q; Harris PC; Frost P; Avner ED
    Kidney Int; 2004 Nov; 66(5):1766-73. PubMed ID: 15496147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease.
    Beck Gooz M; Maldonado EN; Dang Y; Amria MY; Higashiyama S; Abboud HE; Lemasters JJ; Bell PD
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F551-9. PubMed ID: 24899059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
    Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
    Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease.
    Sweeney WE; Avner ED
    Am J Physiol; 1998 Sep; 275(3):F387-94. PubMed ID: 9729511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc antisense oligonucleotide treatment ameliorates murine ARPKD.
    Ricker JL; Mata JE; Iversen PL; Gattone VH
    Kidney Int; 2002 Jan; 61(1 Suppl):S125-31. PubMed ID: 11841626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.
    Lautrette A; Li S; Alili R; Sunnarborg SW; Burtin M; Lee DC; Friedlander G; Terzi F
    Nat Med; 2005 Aug; 11(8):867-74. PubMed ID: 16041383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice.
    Ricker JL; Gattone VH; Calvet JP; Rankin CA
    J Am Soc Nephrol; 2000 Oct; 11(10):1837-1847. PubMed ID: 11004214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells.
    Shao MX; Ueki IF; Nadel JA
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11618-23. PubMed ID: 12972643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor.
    Nauta J; Sweeney WE; Rutledge JC; Avner ED
    Pediatr Res; 1995 Jun; 37(6):755-63. PubMed ID: 7651760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice.
    Veizis EI; Carlin CR; Cotton CU
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F244-54. PubMed ID: 14559716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.